57 results about "Syndrome patient" patented technology

A method of diagnosing heritable arrhythmia syndrome in a patient is disclosed. In one embodiment, the method comprises the steps of (a) isolating a nucleic acid sample from the patient and (b) comparing the nucleic acid sample to the compendium of novel DNA mutations disclosed in Table 1, wherein the comparison is to the mutations described from at least one of the genes selected from the group consisting of KCNQ1, KCNH2, SCN5A, and KCNE2.

The present invention provides compounds for use in the preparation of pharmaceutical formulations and medicaments, which alleviate learning and / or mental impairment in people suffering from Down's syndrome.

The invention discloses a levodopa / benserazide orally disintegrating tablet and a preparation method thereof. The tablet comprises the main drugs including levodopa and benserazide and the auxiliary materials including microcrystalline cellulose, mannitol, lactose, crospolyvinylpyrrolidone, low-substituted hydroxypropyl cellulose, sodium cyclamate, menthol, aerosol and magnesium stearate. The tablet of the invention can effectively treat the Parkinson disease or Parkinsonism syndrome, is convenient to take, good in mouthfeel, quick in disintegration, fast in absorption and high in bioavailability and provides convenience for the Parkinson disease or Parkinsonism syndrome patients who have difficulty in taking the whole tablet or feel inconvenient to take the tablet.

The invention relates to an automatic turnover bed for sleep apnea. The automatic turnover bed comprises a sleep monitor (1), a controller (2), a bed turnover component (3) and an operating instruction display sender (4). By automatically monitoring sleep, snorers, obese people or obstructive sleep apnea syndrome patients automatically turn over when a low blood oxygen index is monitored to relieve or eliminate respiratory obstruction, so that the sleep quality is improved; and different monitoring data is matched with different postures, and when the degree of severe hypoxia is arrived, the sleeper is turned to a sitting position and an alarm is given, so that risk is prevented.

The invention relates to an area of the chemical-pharmaceutical industry and medicine, particularly to an agent for treatment of dementias, including Alzheimer's disease (AD), as well as to a method of treatment and pharmaceutical composition, which is effective for both treatment of dementias, including AD or dementias of Alzheimer type, and during manifestations of the first symptoms of memory disorder.The given invention consists of the development of a new therapeutic substance with minimal side effects that currently is a topical issue for treatment of the corresponding diseases.Attached is the use of polyprenols of formula (1)where n=8-20 as an active ingredient for the production of the therapeutic agent for the treatment of patients with dementia syndrome, including those who suffer from Alzheimer's disease.It is proposed to use a therapeutic agent for the treatment of patients with dementia syndrome, including those suffering from Alzheimer's disease, being polyprenols of formula (1).It was proposed that a pharmaceutical composition for the treatment of patients suffering from dementia syndrome, including patients suffering from Alzheimer disease, being an effective amount of polyprenols of formula (1) and pharmaceutically acceptable additional substances, including carriers and / or solvents, additives and / or lubricants.It was proposed that a method for treatment of patients suffering from dementia syndrome, including patients suffering from Alzheimer's disease, when effective amount of polyprenols of formula (1) is administered in the form of the substance or as a pharmaceutical composition that includes additional components.

The invention discloses a beverage preventing and curing the diabetes and heart cerebrovascular disease, and the beverage comprises a spirituous beverage, and is characterized in that the important microelement chromium necessary to the human body is added into a beverage body or in an inherent raw material formula, and the human body is supplemented with the chromium by using an economic and simple manner, which not only can avoid the diabetes patients from pain of skin of flesh caused by insulin injection, but also can avoid the damage of drugs to internal organs of metabolic syndrome patients. The beverage not only has the characteristics of various preventing and curing and hearth protecting efficacies, wide adaptability, high popularization and application values, and good effect on maintaining heart cerebrovascular heath of the human body, but also has the characteristics of easily and effectively preventing and curing the diabetes, the heart cerebrovascular disease, obesity, fatty liver, hypertension, hyperlipaemia and hypercholesterolemia in a daily diet manner from origins thereof, and having good effects of ageing resistance and health protection.

The invention discloses an obstructive sleep apnea syndrome treatment monitoring system, and aims to solve the technical problem of eliminating harms brought by obstructive sleep apnea syndrome to a patient. The obstructive sleep apnea syndrome treatment monitoring system is provided with a collector, and a health care treatment mattress system used for sending collected patient information to a remote monitoring analysis center and receiving instructions of the remote monitoring analysis center, wherein the health care treatment mattress system is provided with a mattress; and inflatable air bags are arranged on the mattress. Compared with the prior art, the obstructive sleep apnea syndrome treatment monitoring system has the advantage that when a severe / moderate obstructive sleep apnea syndrome patient sleeps, the positions and the heights of the air bags in the mattress are remotely controlled and adjusted according to the prompt of an analysis signal of abnormal blood oxygenation content, so as to help the patient to adjust the sleep posture, open a respiratory tract and comprehensively improve the obstructive sleep apnea syndrome hypoxia phenomenon occurring to the patient in the sleep process; and the obstructive sleep apnea syndrome treatment monitoring system has the characteristics that paralysis is prevented, the sleep quality of the patient is improved, the falling-preventing air bags are provided, and sleep safety of the patient is guaranteed.